Myleran and venoocclusive liver disease Patient Reports February 11, 2012
Myleran Side Effects Report #5391247-9
Myleran side effect was reported by a Consumer or non-health professional from UNITED STATES on July 10, 2007. Female patient was diagnosed with stem cell transplant and was treated with Myleran. After drug was administered, patient experienced the following side effects: venoocclusive liver disease. Myleran dosage: 1 MG/KG / SEE TEXT / ORAL. During the same period patient was treated with ETOPOSIDE, CYCLOPHOSPHAMIDE. Patient died.
Myleran Side Effects Report #4805329-0
Myleran side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Oct 05, 2005. Male patient, 49 years of age, was treated with Myleran. After drug was administered, patient experienced the following side effects: ascites, encephalopathy, international normalised ratio increased, multi-organ failure, venoocclusive liver disease. Myleran dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE. Patient died.
Myleran Side Effects Report #4805358-7
Myleran side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Oct 05, 2005. Female patient, 36 years of age, was treated with Myleran. After drug was administered, patient experienced the following side effects: haemodialysis, international normalised ratio increased, renal impairment, respiratory failure, sepsis
, venoocclusive liver disease. Myleran dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE. Patient died.Myleran Side Effects Report #4805356-3
Myleran side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Oct 05, 2005. Female patient, 34 years of age, was treated with Myleran. After drug was administered, patient experienced the following side effects: encephalopathy, hepatic rupture, peritoneal haemorrhage, venoocclusive liver disease. Myleran dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, THIACETAZONE. Patient died.
Myleran Side Effects Report #4629551-1
Myleran side effect was reported by a Consumer or non-health professional from on Mar 21, 2005. Female patient was treated with Myleran. After drug was administered, patient experienced the following side effects: venoocclusive liver disease. Myleran dosage: 1 MG/KG/ SEE TEXT / ORAL. During the same period patient was treated with ETOPOSIDE, CYCLOPHOSPHAMIDE. Patient died.
Myleran and venoocclusive liver disease 